Showing results (771-780 of 3,103) with videos related to

Sort By:
Pageof 311
Drug Safety|July 6, 2000
Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costsJ C DeToledo, R E Ramsay
Drug Safety|July 6, 2000
Fluoroquinolone-induced renal failureB M Lomaestro
Drug Safety|August 17, 2000
Drug-induced respiratory disorders: incidence, prevention and managementL Ben-Noun
Drug Safety|July 29, 2000
Safety of inhaled and intranasal corticosteroids: lessons for the new millenniumB J Lipworth, C M Jackson
Drug Safety|July 29, 2000
Reporting of adverse drug reactions by poison control centres in the USP A Chyka, S W McCommon
Drug Safety|January 5, 2002
Immunisation safety: a priority of the World Health Organization's Department of Vaccines and BiologicalsP Duclos, C A Hofmann
Drug Safety|January 5, 2002
Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studiesP Weidmann
Drug Safety|June 20, 2002
Signal generation in the New Zealand Intensive Medicines Monitoring Programme: a combined clinical and statistical approachDavid M Coulter
Drug Safety|June 20, 2002
Prescription-event monitoring in Japan (J-PEM)Kiyoshi Kubota
Drug Safety|May 22, 2002
Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysisBahi Takkouche, Mahyar Etminan, Francisco Caamaño, et al.
Pageof 311